Mark A Shaffer sold $669k of LQDT
VP, Gen. Counsel & Secretary at LIQUIDITY SERVICES INC. 19,175 shares at an average of $34.91, traded Feb 10, 2025, filed Feb 12, 2025.
Score components
- +15RoleOfficer
- +20Trade size$669k at market
- +10Share of holdings soldSold 38% of holdings
- +15Cluster7 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -16.1%, 3m -28.9%, 6m -26.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-019231, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 10, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -3,633 | $34.70 | $126k | 46,200 | Feb 12, 2025 |
| Feb 11, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -9,537 | $34.57 | $330k | 36,663 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -580 | $34.62 | $20k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +814 | $17.31 | $14k | 36,897 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -814 | $35.78 | $29k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +231 | $9.46 | $2,185 | 36,314 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -231 | $35.78 | $8,265 | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +720 | $22.20 | $16k | 36,803 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -720 | $35.67 | $26k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +1,313 | $22.20 | $29k | 37,396 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -1,313 | $35.67 | $47k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +1,942 | $14.00 | $27k | 38,025 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -1,942 | $35.67 | $69k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +405 | $14.00 | $5,670 | 36,488 | Feb 12, 2025 |
| Feb 12, 2025 | SOpen-market sale Common Stockindirect: By The Mark A. Shaffer Revocable Trust | -405 | $35.67 | $14k | 36,083 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +322 | $22.20 | $7,148 | 36,405 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +433 | $14.00 | $6,062 | 36,838 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +3,957 | $9.46 | $37k | 40,795 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Common Stockindirect: By The Mark A. Shaffer Revocable Trust | +709 | $17.31 | $12k | 41,504 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -4,443 | $0.00 | $0 | 0 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -5,966 | $0.00 | $0 | 1,774 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -5,419 | $0.00 | $0 | 4,986 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -3,203 | $0.00 | $0 | 8,622 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -3,096 | $0.00 | $0 | 4,644 | Feb 12, 2025 |
| Feb 12, 2025 | MOption exercise Stock Option Grantderivative | -1,040 | $0.00 | $0 | 9,365 | Feb 12, 2025 |
Related signals
Other insiders at LIQUIDITY SERVICES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $31k 715 shares | -2% | |
| 0Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $30k 715 shares | -2% | |
| 0Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $28k 715 shares | -2% | |
| 0Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $18k 462 shares | -1% | |
| 0Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $1,528 39 shares | -0% | |
| 16Weak | LIQUIDITY SERVICES INC | John Daunt EVP, Chief Commercial Officer | $398k 10,139 shares | -21% | |
| 40Moderate | LIQUIDITY SERVICES INC | Jaime Mateus-Tique director | $1.5M 39,482 shares | -19% | |
| 25Weak | LIQUIDITY SERVICES INC | Jaime Mateus-Tique director | $372k 9,791 shares | -5% | |
| 40Moderate | LIQUIDITY SERVICES INC | Jaime Mateus-Tique director | $1.4M 35,727 shares | -14% | |
| 31Weak | LIQUIDITY SERVICES INC | Jorge Celaya EVP & Chief Financial Officer | $92k 2,409 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.